<DOC>
	<DOCNO>NCT01667406</DOCNO>
	<brief_summary>Infertility affect one six couple United Kingdom ( UK ) devastate physical , social emotional consequence affect couple . In vitro fertilisation ( IVF ) treatment widely successfully use enable infertile couple conceive . However , IVF treatment result potentially life threaten condition , ovarian hyperstimulation syndrome ( OHSS ) . Mild form OHSS occur approximately 1 3 IVF cycle , whilst approximately 1 10 IVF cycle result moderate severe OHSS . OHSS cause use human chorionic gonadotrophin ( hCG ) use IVF treatment stimulate oocyte ( egg ) maturation . Kisspeptin hormone stimulate reproductive hormone secretion responsible release reproductive hormone result oocyte maturation ovulation ( release egg ovary ) . The significant advantage kisspeptin current treatment stimulate ovulation , would stimulate physiological increase reproductive hormone oocyte maturation IVF treatment . The aim project investigate whether administration kisspeptin woman result oocyte maturation .</brief_summary>
	<brief_title>The Use Hormone Kisspeptin 'in Vitro Fertilisation ' ( IVF ) Treatment</brief_title>
	<detailed_description>Participants study standard Gonadotrophin Releasing Hormone ( GnRH ) antagonist cycle except use kisspeptin trigger oocyte maturation rather hCG .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Aged 18 34 year Body mass index 18 29 kg/m2 Stable body weight least 3 month Normal early menstrual cycle follicular phase serum FSH concentration Serum antiMullerian hormone ( AMH ) &gt; 40pmol/L No one previous IVF treatment cycle Both ovaries intact History medical , psychological condition , use medication , include overthecounter product , , opinion investigator , would either interfere study potentially cause harm volunteer Without access home telephone , factor likely interfere ability participate reliably study Treatment investigational drug within precede 2 month Donated blood precede 3 month intention end study Previous poor response IVF treatment</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>34 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>kisspeptin</keyword>
	<keyword>infertility</keyword>
	<keyword>vitro fertilisation</keyword>
</DOC>